nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00356	0.154	CbGeAlD
Methotrimeprazine—HTR2A—vein—adrenal gland cancer	0.00333	0.144	CbGeAlD
Methotrimeprazine—Diltiazem—ABCB1—adrenal gland cancer	0.0026	0.157	CrCbGaD
Methotrimeprazine—CYP1A2—urine—adrenal gland cancer	0.0025	0.108	CbGeAlD
Methotrimeprazine—Triflupromazine—ABCB1—adrenal gland cancer	0.00232	0.14	CrCbGaD
Methotrimeprazine—CYP2E1—urine—adrenal gland cancer	0.00225	0.0969	CbGeAlD
Methotrimeprazine—HTR2A—urine—adrenal gland cancer	0.00195	0.0842	CbGeAlD
Methotrimeprazine—Fluphenazine—ABCB1—adrenal gland cancer	0.00178	0.108	CrCbGaD
Methotrimeprazine—CYP2D6—urine—adrenal gland cancer	0.00178	0.0767	CbGeAlD
Methotrimeprazine—Clomipramine—ABCB1—adrenal gland cancer	0.00163	0.0985	CrCbGaD
Methotrimeprazine—Chlorprothixene—ABCB1—adrenal gland cancer	0.00162	0.098	CrCbGaD
Methotrimeprazine—Trimipramine—ABCB1—adrenal gland cancer	0.0015	0.0906	CrCbGaD
Methotrimeprazine—Promethazine—ABCB1—adrenal gland cancer	0.00144	0.0872	CrCbGaD
Methotrimeprazine—Trifluoperazine—ABCB1—adrenal gland cancer	0.00143	0.0861	CrCbGaD
Methotrimeprazine—Chlorpromazine—ABCB1—adrenal gland cancer	0.00112	0.0675	CrCbGaD
Methotrimeprazine—Imipramine—ABCB1—adrenal gland cancer	0.00111	0.0672	CrCbGaD
Methotrimeprazine—ADRA2C—adrenal cortex—adrenal gland cancer	0.000762	0.0329	CbGeAlD
Methotrimeprazine—DRD2—pituitary gland—adrenal gland cancer	0.000633	0.0273	CbGeAlD
Methotrimeprazine—ADRA2C—cardiac atrium—adrenal gland cancer	0.00063	0.0272	CbGeAlD
Methotrimeprazine—ADRA2C—pituitary gland—adrenal gland cancer	0.000616	0.0266	CbGeAlD
Methotrimeprazine—ADRA1A—adrenal gland—adrenal gland cancer	0.000577	0.0249	CbGeAlD
Methotrimeprazine—ADRA2C—adrenal gland—adrenal gland cancer	0.00055	0.0237	CbGeAlD
Methotrimeprazine—ADRA2A—gonad—adrenal gland cancer	0.000504	0.0217	CbGeAlD
Methotrimeprazine—ADRA2A—cardiac atrium—adrenal gland cancer	0.000503	0.0217	CbGeAlD
Methotrimeprazine—ADRA2A—pituitary gland—adrenal gland cancer	0.000491	0.0212	CbGeAlD
Methotrimeprazine—HRH1—adrenal gland—adrenal gland cancer	0.000447	0.0193	CbGeAlD
Methotrimeprazine—ADRA2A—adrenal gland—adrenal gland cancer	0.000439	0.0189	CbGeAlD
Methotrimeprazine—CYP2E1—adrenal gland—adrenal gland cancer	0.000429	0.0185	CbGeAlD
Methotrimeprazine—HTR2A—gonad—adrenal gland cancer	0.000428	0.0185	CbGeAlD
Methotrimeprazine—HTR2A—pituitary gland—adrenal gland cancer	0.000418	0.018	CbGeAlD
Methotrimeprazine—HTR2A—adrenal gland—adrenal gland cancer	0.000373	0.0161	CbGeAlD
Methotrimeprazine—DRD4—Signaling Pathways—TERT—adrenal gland cancer	0.00021	0.000218	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.00021	0.000218	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.00021	0.000218	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00021	0.000218	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000209	0.000218	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000209	0.000217	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000208	0.000217	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.000207	0.000216	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000206	0.000215	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000206	0.000215	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000206	0.000214	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000206	0.000214	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000205	0.000214	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000205	0.000214	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000204	0.000213	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000202	0.000211	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000202	0.00021	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000202	0.00021	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000201	0.00021	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.0002	0.000209	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.0002	0.000209	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.000198	0.000206	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000198	0.000206	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000196	0.000204	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000195	0.000204	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000194	0.000202	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000194	0.000202	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	0.000194	0.000202	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000193	0.000201	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000192	0.0002	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000191	0.000199	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.00019	0.000198	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.00019	0.000198	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000189	0.000197	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000189	0.000197	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TERT—adrenal gland cancer	0.000189	0.000197	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000189	0.000197	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000189	0.000197	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000188	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000188	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000187	0.000195	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000187	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000186	0.000194	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	0.000186	0.000194	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.000186	0.000194	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000186	0.000194	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000184	0.000192	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000183	0.00019	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—BAD—adrenal gland cancer	0.000182	0.00019	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000182	0.000189	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.00018	0.000187	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.00018	0.000187	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000178	0.000186	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000178	0.000185	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000176	0.000184	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000175	0.000182	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.000175	0.000182	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000174	0.000181	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000173	0.000181	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000173	0.00018	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000172	0.00018	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000172	0.000179	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000171	0.000178	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000171	0.000178	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.00017	0.000177	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.00017	0.000177	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000169	0.000176	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—POMC—adrenal gland cancer	0.000168	0.000175	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000168	0.000175	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000168	0.000175	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000168	0.000175	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000167	0.000174	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000167	0.000174	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000167	0.000174	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000167	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000166	0.000173	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	0.000166	0.000173	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.000166	0.000173	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000166	0.000173	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000166	0.000172	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000166	0.000172	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000165	0.000172	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—BAD—adrenal gland cancer	0.000164	0.000171	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000164	0.000171	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.000164	0.000171	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000164	0.000171	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000164	0.00017	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000163	0.00017	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000163	0.000169	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000163	0.000169	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000162	0.000169	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—BAD—adrenal gland cancer	0.000162	0.000169	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	0.000162	0.000169	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000162	0.000168	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000162	0.000168	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000161	0.000168	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.00016	0.000167	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00016	0.000166	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000159	0.000166	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000159	0.000166	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000159	0.000165	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000157	0.000164	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000157	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000155	0.000161	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000153	0.00016	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000152	0.000158	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000152	0.000158	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000152	0.000158	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—POMC—adrenal gland cancer	0.000151	0.000158	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000151	0.000157	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	0.00015	0.000156	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	0.000149	0.000156	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—POMC—adrenal gland cancer	0.000149	0.000156	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000148	0.000154	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000148	0.000154	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	0.000148	0.000154	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000146	0.000152	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000146	0.000152	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000145	0.000151	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000143	0.000149	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000143	0.000149	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000143	0.000149	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	0.000143	0.000148	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000141	0.000146	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.00014	0.000146	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.00014	0.000146	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.00014	0.000145	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000139	0.000145	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000138	0.000143	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000137	0.000143	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000137	0.000142	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000135	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.000135	0.00014	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000133	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000133	0.000139	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.00013	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000129	0.000134	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	0.000129	0.000134	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000128	0.000133	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000128	0.000133	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000126	0.000131	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000124	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	0.000124	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000124	0.000129	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000124	0.000129	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000124	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000122	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000122	0.000127	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000122	0.000127	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.000122	0.000127	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000121	0.000126	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000121	0.000126	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000121	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000121	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.00012	0.000125	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00012	0.000125	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.00012	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.00012	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000119	0.000124	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000118	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000118	0.000123	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000116	0.000121	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	0.000114	0.000119	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000113	0.000118	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	0.000113	0.000118	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000113	0.000117	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000112	0.000117	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	0.000112	0.000117	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000112	0.000117	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000112	0.000116	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000111	0.000116	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000111	0.000116	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	0.000111	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000111	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.00011	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.00011	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.00011	0.000115	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000109	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000109	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000109	0.000113	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—adrenal gland cancer	0.000108	0.000113	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000108	0.000113	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000108	0.000112	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000107	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000107	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000107	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000107	0.000111	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000107	0.000111	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000106	0.000111	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000106	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000105	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000102	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000101	0.000105	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.0001	0.000105	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	9.85e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	9.8e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	9.76e-05	0.000102	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	9.63e-05	0.0001	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	9.51e-05	9.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	9.38e-05	9.77e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	9.25e-05	9.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	8.99e-05	9.37e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	8.99e-05	9.36e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	8.97e-05	9.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	8.85e-05	9.22e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	8.56e-05	8.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	8.45e-05	8.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	8.45e-05	8.8e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	8.16e-05	8.5e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	8.03e-05	8.36e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	8.01e-05	8.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	7.99e-05	8.32e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—adrenal gland cancer	7.99e-05	8.32e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—POMC—adrenal gland cancer	7.98e-05	8.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	7.96e-05	8.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	7.88e-05	8.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	7.88e-05	8.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.86e-05	8.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	7.63e-05	7.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	7.55e-05	7.86e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	7.33e-05	7.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	7.31e-05	7.61e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—adrenal gland cancer	7.19e-05	7.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	7.13e-05	7.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	7.09e-05	7.39e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—adrenal gland cancer	7.09e-05	7.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	7.01e-05	7.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—POMC—adrenal gland cancer	6.76e-05	7.04e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	6.47e-05	6.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	6.4e-05	6.67e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	6.36e-05	6.63e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	6.36e-05	6.62e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	6.35e-05	6.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	6.33e-05	6.59e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	6.31e-05	6.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	6.25e-05	6.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	6.23e-05	6.49e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	6.15e-05	6.41e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	5.98e-05	6.23e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	5.89e-05	6.13e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	5.79e-05	6.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	5.43e-05	5.65e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	5.39e-05	5.61e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	5.34e-05	5.56e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	5.33e-05	5.55e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	5.31e-05	5.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	5.3e-05	5.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	5.24e-05	5.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	5.23e-05	5.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	4.86e-05	5.06e-05	CbGpPWpGaD
